VIB
Overview
VIB is an entrepreneurial non-profit research institute based in Belgium that conducts strategic basic research in life sciences and actively engages in technology transfer, including the incubation and investment in biotech spin-off companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Rainbow Crops | Jun 2026 | Seed | Co-investor |
| Muna Therapeutics | Jul 2021 | Series A | Co-investor |
| Augustine Therapeutics | Mar 2025 | Series A | Co-investor |
| Aphea.Bio | Apr 2021 | Series B | Co-investor |
| Muna Technologies | - | Seed | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is VIB based?
VIB is headquartered in Belgium.
When was VIB founded?
VIB was founded in 1995.
How many portfolio companies does VIB have?
VIB has 15 portfolio companies in Caplight's dataset.
What are some companies in VIB's portfolio?
Portfolio companies visible on Caplight include Rainbow Crops, Muna Therapeutics, Augustine Therapeutics, Aphea.Bio, Muna Technologies.
What was VIB's most recent investment shown here?
VIB's most recent investment in this portfolio sample was in Rainbow Crops in 2026.
What sectors does VIB focus on?
VIB focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Enterprise Software, Healthcare & Life Sciences, Energy & Sustainability, FinTech, Frontier & Industrial Tech, Healthcare & Life Sciences.
What company stages does VIB focus on?
VIB typically invests at the Early stage.
What is VIB's AUM?
VIB's assets under management are estimated between $100.0M and $250.0M.